Another significant dilution will be coming before end of year. So call me a basher but it will happen (jmo). People told me I was wrong and a basher when I had stated no FDA approval in 2016. Well, I guess some people believe being right by being negative is being a basher.
What happens when the company runs through the 300M+ shares (as it will)? Control expenses, the company won't. I think it should be obvious but just think about that RS. It will happen. Then you can take that money you think you will make and it will take 10x's more in the pps to just break even. Well you can hype again about doubling down.